IFNG and neoplasm: Under IFN-γ priming, MSCs increase the expression of class II histocompatibility leukocyte antigen (HLA) molecules [51], and MCSs preconditioning with IFN-γ and TNF-α in combination promoted angiogenesis and accelerated tumor growth [52].